What Is the Pharmacist’s Role in Managing mHSPC Doublet and Triplet Regimens?
Lisa Holle, PharmD, BCOP, FHOPA, FISOPP
Expert Panel: How Does ADT Intensification for mHSPC Affect Future Therapy Options?
Alicia K. Morgans, MD, MPH
Kelvin A. Moses, MD, PhD, FACS
Choosing Between Doublets and Triplets in mHSPC: What Is the Data?
What Is the Current State of Disparities in Prostate Cancer Care?
Expert Panel: How Can We Integrate Patient Preference Data To Support Shared Decision-Making Conversations in mHSPC?
What Can I Do to Improve Care of Prostate Cancer Patients at Risk for Inequities?
How Nurses and Advanced Practice Clinicians Can Help Patients Navigate a New mHSPC Diagnosis
Stacy Walker, NP
Expert Panel: Selecting Treatment in mHSPC: Which Treatment for Which Patient?
Intensifying ADT in mHSPC: How to Improve Patient Outcomes and Adherence
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We’re glad to see you’re enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.